ES451113A1 - Improvement of organic compound - Google Patents

Improvement of organic compound

Info

Publication number
ES451113A1
ES451113A1 ES451113A ES451113A ES451113A1 ES 451113 A1 ES451113 A1 ES 451113A1 ES 451113 A ES451113 A ES 451113A ES 451113 A ES451113 A ES 451113A ES 451113 A1 ES451113 A1 ES 451113A1
Authority
ES
Spain
Prior art keywords
carbon atoms
group containing
formula
nitrogen atom
see formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES451113A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES451113A1 publication Critical patent/ES451113A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

Procedure for preparing oxamic acid derivatives of formula I **(See formula)** where it's hydrogen, chlorine or bromine, R2 is hydrogen or an alkyl group containing 1 to 4 carbon atoms, R3 is hydrogen, an alkyl group containing 1 to 4 carbon atoms, an alkenyl or alkynyl group containing 3 to 5 carbon atoms, the multiple bond of which is not adjacent to the nitrogen atom, a cycloalkyl group containing 5 or 6 carbon atoms carbon or a hydroxyalkyl group containing 2 to 4 carbon atoms, the hydroxy group of which is separated from the nitrogen atom by at least 2 carbon atoms, R4 is an alkyl group containing 1 to 4 carbon atoms, an alkenyl or alkynyl group containing 3 to 5 carbon atoms, the multiple bond of which is not adjacent to the nitrogen atom, a cycloalkyl group containing 5 or 6 carbon atoms, a hydroxyalkyl group containing 2 to 4 carbon atoms, the hydroxy group of which is separated from the nitrogen atom by at least 2 carbon atoms or, in the case of hydrogen or an alkyl group containing 1 to 4 carbon atoms, it also means a phenyl or phenylalkyl group whose alkylene chain contains 1 to 4 carbon atoms and which may be mono- or disubstituted in the phenyl ring by fluorine, chlorine, bromine or an alkyl or alkoxy group containing 1 to 4 carbon atoms, or a pyridinyl group or a pyrimidinyl group optionally substituted by 1 or 2 methyl groups, or R3 and R4 together with the nitrogen atom to which they are linked, signify a group (see formula) where X is -CH2-, -0- or a bond, and the salts of the acids of formula I, characterized in that they are reacted reactive acid derivatives of sulfonic acids of formula II **(See formula)** where it has the previously indicated meaning and R2 is alkyl of 1 to 4 carbon atoms, with amines of formula III **(See formula)** wherein R3 and R4 have the previously indicated meanings, preferably in the presence of an inert organic solvent, at temperatures between 0 and 100ºC, preferably around 10-25ºC, and the resulting compounds of formula Ia **(See formula)** Where R1, R3, R4 and R2'have the previously indicated meanings, they are optionally hydrolyzed to provide compounds of formula Ib **(See formula)** wherein R1, R3 and R4 have the previously indicated meanings, preferably in the presence of dilute bases, at ambient to boiling temperatures of the reaction mixture and optionally in the presence of an inert organic solvent. (Machine-translation by Google Translate, not legally binding)
ES451113A 1975-09-02 1976-08-31 Improvement of organic compound Expired ES451113A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1136675 1975-09-02
CH1136775 1975-09-02
CH1419475 1975-11-04
CH21876 1976-01-09

Publications (1)

Publication Number Publication Date
ES451113A1 true ES451113A1 (en) 1977-11-16

Family

ID=27427797

Family Applications (1)

Application Number Title Priority Date Filing Date
ES451113A Expired ES451113A1 (en) 1975-09-02 1976-08-31 Improvement of organic compound

Country Status (11)

Country Link
JP (1) JPS5233645A (en)
AU (1) AU1737376A (en)
DE (1) DE2637882A1 (en)
DK (1) DK380176A (en)
ES (1) ES451113A1 (en)
FI (1) FI762419A (en)
FR (1) FR2322592A1 (en)
IL (1) IL50390A0 (en)
NO (1) NO762922L (en)
PT (1) PT65538B (en)
SE (1) SE7609494L (en)

Also Published As

Publication number Publication date
FR2322592A1 (en) 1977-04-01
PT65538A (en) 1976-09-01
DE2637882A1 (en) 1977-03-03
FI762419A (en) 1977-03-03
SE7609494L (en) 1977-03-03
IL50390A0 (en) 1976-10-31
FR2322592B1 (en) 1978-11-17
AU1737376A (en) 1978-03-09
JPS5233645A (en) 1977-03-14
PT65538B (en) 1978-05-10
DK380176A (en) 1977-03-03
NO762922L (en) 1977-03-03

Similar Documents

Publication Publication Date Title
ES479369A1 (en) Spiro-(dihydrobenzofuranpiperidines and -pyrrolidines) and derivatives thereof, methods for their preparation and medicines containing them.
ES8802039A1 (en) 1-Piperazine carboxamide derivatives, their preparation and their use in pharmaceutical compositions.
ES439548A1 (en) 8alpha-substituted ergoline i derivatives
ES8606381A1 (en) Novel 2'-deoxy-5-substituted uridine derivatives, processes for preparing the same and antitumor agent containing the same.
IL58256A (en) N-pyrrolyl-pyridazineamines,process for their manufacture and antihypertensive compositions containing them
KR830001911A (en) Manufacturing method of heterocyclic derivatives
ES470916A1 (en) 4-Hydroxy-2-quinolinone-3-carboxylic acids, their preparation and pharmaceutical compositions containing them.
ES451113A1 (en) Improvement of organic compound
KR880007490A (en) Substituted aminopropionamides, methods of preparation thereof, medicaments containing the same, uses thereof and intermediates produced during the preparation thereof
SE7612685L (en) PROCEDURE FOR PREPARING NEW IMIDAZOLE COMPOUNDS
GB1008849A (en) Basically substituted triazolidines, processes for their manufacture and pharmaceutical preparations containing them
ES444779A1 (en) Substituted cyclic phosphine oxides
ES424088A1 (en) Novel organotin compounds
ES8104309A1 (en) Process for preparing enamine derivatives, compounds so produced and process for preparing a 3-hydroxy-cephalosporin.
ES425576A1 (en) Pyrazoles and process for their preparation
ES444521A1 (en) Biocidal uses of pyridyltriazinone compounds
DK193180A (en) PROCEDURE FOR THE PREPARATION OF 2-AMINOALKYL5-PYRIDINOLES THEIR ACID ADDITION SALTS AND PREPARATIONS CONTAINING THESE COMPOUNDS
GB1021511A (en) New alkylphosphonothioates and pesticidal compositions containing them
ES423745A1 (en) Procedure for preparing 2-aminoindane derivatives. (Machine-translation by Google Translate, not legally binding)
ES434406A1 (en) Octahydrobenzo(c)(1,6)naphthyridines
ES362369A1 (en) Isonipecotic acid derivatives
ES364722A1 (en) Procedure for the preparation of new derivatives of paminoalquil-bencensulfonamida. (Machine-translation by Google Translate, not legally binding)
ES278109A1 (en) Procedure for the preparation of new N-heterocyclic compounds (Machine-translation by Google Translate, not legally binding)
ES405275A1 (en) 3-amino-2h,5,6-dihydro-1,4-oxazines and salts thereof
ES432477A1 (en) Procedure for the preparation of new derivatives of bifenilo. (Machine-translation by Google Translate, not legally binding)